PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT06590194 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06590194
- Sponsor
- Suzhou Puhe Pharmaceutical Technology Co., LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-10
- Primary completion
- 2026-06-30
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.